ARQT vs WAB · rev $235.3M vs P/E 38, rev $3.18B
Arcutis Biotherapeutics Inc (ARQT) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
Latest reported WAB revenue for 2026-06-30 was $3.18B. Net income was $395.0M. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
ARQT currently screens at market cap $1.64B. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the ARQT and WAB stock pages for the full models.
Not investment advice.